Technical Roundup on Medical Appliances and Equipment Stocks -- ZELTIQ Aesthetics, Align Technology, Nxstage Medical, and Nevro
PR Newswire - 2 hrs 10 mins ago
One of the U.S. Healthcare sector's biggest segments, the Medical Appliances and Equipment is expected to face challenges due to stiff competition and economic uncertainties. However, constant need and demand for medical instruments should continue to drive industry growth, and the segment is anticipated to grow at a CAGR rate of about 6% through 2017, according to Espicom's 2014 report. Stock-Callers.com looks closely at the following stocks today: ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), Align Technology Inc. (NASDAQ: ALGN), Nxstage Medical Inc. (NASDAQ: NXTM), and Nevro Corp. (NYSE: NVRO). Sign up today and download for free the research reports for the stocks covered today at:
NXTM: 22.15 (+0.04), ZLTQ: 33.74 (-0.21), ALGN: 88.98 (-0.17), NVRO: 82.41 (-0.29)
Zacks.com featured highlights: Conns, ZELTIQ Aesthetics, PTC, DreamWorks Animation SKG and Covanta Holding
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:30AM CDT
Zacks.com featured highlights: Conns, ZELTIQ Aesthetics, PTC, DreamWorks Animation SKG and Covanta Holding
CVA: 15.86 (-0.16), ZLTQ: 33.74 (-0.21), CONN: 7.00 (-0.11), DWA: 40.97 (unch), PTC: 40.27 (+0.54)
Discard These 5 Toxic Stocks Now to Protect Your Portfolio
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:26AM CDT
Overpricing of toxic stocks can be attributed to either an irrational exuberance or some serious drawbacks.
CVA: 15.86 (-0.16), ZLTQ: 33.74 (-0.21), CONN: 7.00 (-0.11), DWA: 40.97 (unch), PTC: 40.27 (+0.54)
Zacks.com featured highlights: Covanta, ZELTIQ Aesthetics, DreamWorks Animation SKG, ViaSat and Live Nation Entertainment
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 8:30AM CDT
Zacks.com featured highlights: Covanta, ZELTIQ Aesthetics, DreamWorks Animation SKG, ViaSat and Live Nation Entertainment
CVA: 15.86 (-0.16), ZLTQ: 33.74 (-0.21), DWA: 40.97 (unch), LYV: 27.08 (-0.34), VSAT: 73.88 (+0.05)
ZELTIQ Aesthetics Stock Sees Short Interest Jump 11.6%
MarketNewsVideo.com - Wed Jul 13, 12:50PM CDT
The most recent short interest data has been released for the 06/30/2016 settlement date, which shows a 1,150,074 share increase in total short interest for ZELTIQ Aesthetics Inc. , to 11,070,614, an increase of 11.59% since 06/15/2016.
ZLTQ: 33.74 (-0.21)
Get Rid of These 5 Toxic Stocks to Protect Your Portfolio
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 8:43AM CDT
Overpricing of toxic stocks may be due to the irrational exuberance associated with them or due to some serious fundamental lacunae.
CVA: 15.86 (-0.16), ZLTQ: 33.74 (-0.21), DWA: 40.97 (unch), LYV: 27.08 (-0.34), VSAT: 73.88 (+0.05)
Why Investors Love These Medical Appliances & Equipment's Stocks? - Align Technology, ZELTIQ Aesthetics, Amedica, and Nxstage Medical
PR Newswire - Wed Jun 22, 6:45AM CDT
Growth is expected for the U.S. Medical Appliances and Equipment industry as demand for healthcare continues to rise. In today's pre-market research, Stock-Callers.com shifts its attention on these four equities for investors' close review: Align Technology Inc. (NASDAQ: ALGN), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), Amedica Corp. (NASDAQ: AMDA), and Nxstage Medical Inc. (NASDAQ: NXTM). Learn more about these stocks and receive your complimentary trade alerts at:
NXTM: 22.15 (+0.04), ZLTQ: 33.74 (-0.21), ALGN: 88.98 (-0.17), AMDA: 0.82 (-0.01)
5 Toxic Stocks to Discard from Your Portfolio Right Now
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 7:27AM CDT
Identifying toxic stocks on a regular basis and removing them from one's portfolio is a secret to investing success.
VRTX: 97.65 (+0.65), ZLTQ: 33.74 (-0.21), ULTI: 209.76 (+0.66), LGF: 20.10 (+0.11), CRM: 81.19 (-0.61)
ZELTIQ Aesthetics, Inc. to Present at Two Upcoming Conferences
Marketwired - Tue May 31, 3:01PM CDT
PLEASANTON, CA --(Marketwired - May 31, 2016) - ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Taylor Harris, Senior Vice President and Chief Financial Officer, are scheduled to present at two upcoming conferences. The first presentation will be at the Goldman Sachs 37th Annual Global Healthcare Conference in Rancho Palos Verdes, CA.
ZLTQ: 33.74 (-0.21)
Zeltiq reports 1Q loss
Automated Insights - Tue May 10, 3:25PM CDT
PLEASANTON, Calif. (AP) _ Zeltiq Aesthetics Inc. (ZLTQ) on Tuesday reported a loss of $9.9 million in its first quarter.
ZLTQ: 33.74 (-0.21)
ZELTIQ Announces First Quarter 2016 Financial Results
Marketwire Canada - Tue May 10, 3:01PM CDT
Increases Revenue Guidance to a Range of $320 Million to $325 Million; Received FDA Clearance to Treat Fat Around Bra Straps, on the Back and Underneath the Buttocks; Launched CoolAdvantage(TM) Family of Applicators With 35 Minute Treatment Times; North America Account Utilization up 26% Year-over-Year
ZLTQ: 33.74 (-0.21)
NovaBay Pharmaceuticals Appoints Todd Zavodnick to its Board of Directors
BusinessWire - Mon May 09, 3:30PM CDT
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its Avenova(R) lid and lash hygiene product for the domestic eye care market, announces the appointment of Todd Zavodnick to its Board of Directors, effective May 6, 2016. Mr. Zavodnick brings extensive senior management and commercial experience in the medical technology and pharmaceutical industries, including serving in a senior capacity at the global ophthalmology company Alcon Laboratories. Mr. Zavodnick will serve on the Audit and Nominating and Corporate Governance committees and replaces Massimo Radaelli, Ph.D., who resigned as a Director of NovaBay effective May 6, 2016. NovaBay's Board membership remains at eight.
ZLTQ: 33.74 (-0.21), NBY: 2.34 (-0.01)
Medical Stocks' Q1 Earnings Releases on May 10: ICUI, ZLTQ
Zacks Equity Research - Zacks Investment Research - Mon May 09, 9:44AM CDT
The two popular names in the medical space, gearing up to report results on May 10, are ICUI and ZLTQ.
ICUI: 117.44 (+0.68), ZLTQ: 33.74 (-0.21)
Hospira President, David J. Endicott, Joins ZELTIQ Aesthetics Board of Directors
Marketwired - Tue Apr 26, 8:04AM CDT
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced David J. Endicott has joined its Board of Directors.
ZLTQ: 33.74 (-0.21)
Award-Winning CoolSculpting(R) Procedure Now FDA-Cleared to Reduce Fat Around Bra Straps, on the Back and Underneath the Buttocks
Marketwired - Tue Apr 05, 8:03AM CDT
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced that it received an expanded clearance from the U.S. Food and Drug Administration (FDA) for the treatment of visible fat bulges of bra fat, back fat and underneath the buttocks (also known as banana roll). The CoolSculpting® procedure is already FDA-cleared for treatment of the double chin (submental area), thigh, abdomen and love handles (flank).
ZLTQ: 33.74 (-0.21)
ZELTIQ to Present at the 28th Annual ROTH Conference
Marketwired - Wed Mar 09, 3:01PM CST
ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer is scheduled to present at the 28th Annual ROTH Conference in Laguna Niguel, CA.
ZLTQ: 33.74 (-0.21)
Citizens Financial to join the S&P 500
M2 - Wed Feb 03, 7:40AM CST
S&P Dow Jones Indices has reported it will replace Precision Castparts Corp. (NYSE: PCP) with Citizens Financial Group Inc. (NYSE: CFG) in the S&P 500 after the close of trading on Friday, January 29, the company said. S&P 100 & 500 constituent Berkshire Hathaway Inc. (NYSE: BRK.
RMAX: 43.16 (-0.16), ZLTQ: 33.74 (-0.21), PBY: 18.50 (+0.01), CFG: 22.37 (+0.04), IEP: 54.55 (+1.06), MDAS: 31.35 (+0.01), MHFI: 107.92 (+1.16), BRK.B: 144.17 (-0.10), PCP: 234.95 (+0.10)
Medical Appliances & Equipment Equities Ahead of Market -- ResMed, ZELTIQ Aesthetics, MiMedx Group, and Varian Medical Systems
ACCESSWIRE - Wed Feb 03, 7:04AM CST
NEW YORK, NY / ACCESSWIRE / February 3, 2016 / Park Lane Advisor has initiated coverage on the following equities: ResMed Inc. (NYSE: RMD), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), MiMedx Group Inc. (NASDAQ: MDXG), and Varian Medical Systems Inc. (NYSE: VAR). Free research report on ResMed can be accessed at http://www.parklaneadvisor.com/ On Tuesday, February 02, 2016, the NASDAQ Composite ended at 4,516.95, down 2.24%, the Dow Jones Industrial Average declined 1.80%, to finish the day at 16,153.54, and the S&P 500 closed at 1,903.03, down 1.87%. Register for your complimentary reports at the links given below.
ZLTQ: 33.74 (-0.21), VAR: 94.98 (+0.24), RMD: 69.71 (+0.83), MDSY: 1.47 (unch), MDXG: 7.63 (+0.14)